Abbott Laboratories - Aug. 11, 2015

$117.00
The reporting of the status of the corrective action (CA) for numerous PRISM HCV Masterlot and bulk conjugate failures described in Exceptions Reports (ERs): ERs 327936, 344931, 357007, and 358551, was not conducted in a timely manner.